UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Temozolomide in malignant gliomas: current use and future targets

Cancer chemotherapy and pharmacology, 2009-09, Vol.64 (4), p.647-655

2009

Link zum Volltext

Verfügbarkeit prüfen

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma

Journal of clinical oncology, 2018-02, Vol.36 (4), p.359-366

2018

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide in malignant gliomas: current use and future targets

Cancer chemotherapy and pharmacology, 2009-09, Vol.64 (4), p.647-655

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of MK‐2206, an allosteric inhibitor of AKT, as second‐line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)

Cancer, 2015-07, Vol.121 (13), p.2193-2197

2015

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib

Clinical and molecular hepatology, 2014-06, Vol.20 (2), p.218-222

2014

Link zum Volltext

Verfügbarkeit prüfen

Role of Primary Tumor Resection Among Chemotherapy-Treated Patients with Synchronous Stage IV Colorectal Cancer: A Survival Analysis

Journal of gastrointestinal surgery, 2014-03, Vol.18 (3), p.592-598

2014

Link zum Volltext

Verfügbarkeit prüfen

Current Options for Third-Line Treatment of Metastatic Colorectal Cancer

Clinical advances in hematology & oncology, 2016-03, Vol.14 (3 Suppl 3), p.1-15

2016

Link zum Volltext

Verfügbarkeit prüfen

Mortality Risk After Preoperative Versus Postoperative Chemotherapy and Radiotherapy in Lymph Node-Positive Rectal Cancer

Journal of gastrointestinal surgery, 2013-02, Vol.17 (2), p.374-381

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT120: Axitinib safety and pharmacokinetics in Child-Pugh A and Child-Pugh B patients with advanced hepatocellular cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.CT120-CT120

2015

Link zum Volltext

Verfügbarkeit prüfen

Liver Imaging : Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib

Clinical and molecular hepatology, 2014-06, Vol.20 (2), p.218

2014

Link zum Volltext

Verfügbarkeit prüfen

The Prevalence of Second Malignancies and Autoimmune Diseases in Patients with Lymphoproliferative Disorders

Blood, 2006-11, Vol.108 (11), p.4608-4608

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Journal of clinical oncology, 2019-05, Vol.37 (13), p.1062-1069

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT066: Global phase 3, randomized, double-blind, placebo-controlled study evaluating PEGylated recombinant human hyaluronidase PH20 (PEGPH20) plus nab-paclitaxel and gemcitabine in patients with previously untreated, hyaluronan (HA)-high, stage IV pancreatic ductal adenocarcinoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT066-CT066

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase IB/II randomized study of mFOLFIRINOX (mFFOX) + pegylated recombinant human hyaluronidase (PEGPH20) versus mFFOX alone in patients with good performance status metastatic pancreatic adenocarcinoma (mPC): SWOG S1313 (NCT #01959139)

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.208-208

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(15)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

Journal Of Clinical Oncology
(3)
Cancer Chemotherapy And Pharmacology
(2)
Cancer Research
(2)
Clinical And Molecular Hepatology
(2)
Journal Of Gastrointestinal Surgery
(2)
Blood
(1)
Cancer
(1)
Clinical Advances In Hematology & Oncology
(1)
Jama Oncology
(1)

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Temozolomide in malignant gliomas: current use and future targets

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma

Temozolomide in malignant gliomas: current use and future targets

Phase 2 study of MK‐2206, an allosteric inhibitor of AKT, as second‐line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)

Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial

Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib

Role of Primary Tumor Resection Among Chemotherapy-Treated Patients with Synchronous Stage IV Colorectal Cancer: A Survival Analysis

Current Options for Third-Line Treatment of Metastatic Colorectal Cancer

Mortality Risk After Preoperative Versus Postoperative Chemotherapy and Radiotherapy in Lymph Node-Positive Rectal Cancer

Abstract CT120: Axitinib safety and pharmacokinetics in Child-Pugh A and Child-Pugh B patients with advanced hepatocellular cancer

Liver Imaging : Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib

The Prevalence of Second Malignancies and Autoimmune Diseases in Patients with Lymphoproliferative Disorders

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Abstract CT066: Global phase 3, randomized, double-blind, placebo-controlled study evaluating PEGylated recombinant human hyaluronidase PH20 (PEGPH20) plus nab-paclitaxel and gemcitabine in patients with previously untreated, hyaluronan (HA)-high, stage IV pancreatic ductal adenocarcinoma

A phase IB/II randomized study of mFOLFIRINOX (mFFOX) + pegylated recombinant human hyaluronidase (PEGPH20) versus mFFOX alone in patients with good performance status metastatic pancreatic adenocarcinoma (mPC): SWOG S1313 (NCT #01959139)

Suchergebnisse filtern